Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 46, 2017 - Issue 5
439
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiuhua Yao, Jiarui Zhao, Qingfei Kong, Xiaoli Xie, Jinghua Wang, Bo Sun, Lixia Xu, Lili Mu & Hulun Li. (2018) Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats. Immunological Investigations 47:7, pages 712-724.
Read now

Articles from other publishers (13)

Masatoshi Hayashi. (2023) Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background. Pathophysiology 30:4, pages 599-617.
Crossref
Emel Koseoglu, Neslihan Sungur, Sabahattin Muhtaroglu, Gokmen Zararsiz & Ahmet Eken. (2022) The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms. Cellular and Molecular Neurobiology 43:5, pages 2071-2087.
Crossref
Hye Yoon Chung, Min Ju Kim, Seung Woo Kim, Jeeyoung Oh & Ha Young Shin. (2023) Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis. Journal of Clinical Neurology 19:1, pages 60.
Crossref
Maartje G Huijbers, Alexander Marx, Jaap J Plomp, Rozen Le Panse & William D Phillips. (2022) Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. The Lancet Neurology 21:2, pages 163-175.
Crossref
Yhojan Rodríguez, Lucas Restrepo, Christopher Chang & Juan-Manuel Anaya. 2022. Allergic and Immunologic Diseases. Allergic and Immunologic Diseases 887 975 .
Christian W. Keller, Marc Pawlitzki, Heinz Wiendl & Jan D. Lünemann. (2021) Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. International Journal of Molecular Sciences 22:11, pages 5755.
Crossref
Masaharu Takamori. (2020) Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability. Frontiers in Molecular Neuroscience 13.
Crossref
Gloria J. Godoy, Carolina Olivera, Daniela A. Paira, Florencia C. Salazar, Yamile Ana, Cinthia C. Stempin, Ruben D. Motrich & Virginia E. Rivero. (2019) T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors. Frontiers in Immunology 10.
Crossref
Inga Koneczny & Ruth Herbst. (2019) Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Cells 8:7, pages 671.
Crossref
Nils Erik Gilhus, Socrates Tzartos, Amelia Evoli, Jacqueline Palace, Ted M. Burns & Jan J. G. M. Verschuuren. (2019) Myasthenia gravis. Nature Reviews Disease Primers 5:1.
Crossref
Renato Mantegazza, Pia Bernasconi & Paola Cavalcante. (2018) Myasthenia gravis: from autoantibodies to therapy. Current Opinion in Neurology 31:5, pages 517-525.
Crossref
Richard Webster. (2018) Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes. International Journal of Molecular Sciences 19:5, pages 1326.
Crossref
Jianwen Wang, Yatao Xiao, Kejing Zhang, Benyan Luo & Chengyong Shen. (2018) Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis. Neuroscience 374, pages 264-270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.